Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chiron seeks U.K. approval for meningitis vaccine

Sep. 14, 1999

Merck & Co. launches preservative-free HBV vaccine

Sep. 13, 1999

Selective glucocorticoid receptor modulators emerge from Abbott-Ligand collaboration

Sep. 13, 1999

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Sep. 8, 1999

Novel B-cell-selective immunomodulators useful in transplantation, autoimmune diseases

Sep. 6, 1999

Orally active prodigiosine compounds claimed for immunosuppression, Rx of T-cell leukemia-lymphoma

Sep. 3, 1999

PowderJect begins clinical study of DNA malaria vaccine

Sep. 3, 1999

Stanford team develops effective method for topical genetic immunization

Sep. 2, 1999

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Sep. 2, 1999

SciClone licenses new class of immunomodulators from University of California

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...